Wanli Cao

Shanghai Changzheng Hospital

Papers

2

Total Citations

55

H-Index

2

About

Wanli Cao is a leading urological surgeon and researcher whose work focuses on advancing surgical techniques for prostate cancer treatment, particularly through evidence-based comparisons of robotic-assisted and laparoscopic approaches. His major contributions include conducting the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies comparing robotic-assisted radical prostatectomy (RARP) to laparoscopic radical prostatectomy (LRP). This landmark 2023 study, which has garnered 49 citations, provided crucial clarity on the relative benefits of these minimally invasive procedures, helping to guide clinical decision-making in urology. Additionally, Cao has investigated perioperative care protocols, such as the necessity of pelvic drain placement after robot-assisted radical prostatectomy, through meta-analyses that inform best practices and reduce unnecessary interventions. His work is characterized by rigorous methodology and a focus on optimizing patient outcomes. With his research cited over 55 times, Cao is recognized as a rising authority in urologic oncology, contributing to the evidence base that shapes modern prostate cancer surgery and postoperative management.

Research Focus

Key Achievements

2
H-Index
2
Papers
55
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted versus laparoscopic radical prostatectomy for prostate cancer: the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies
49 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Shanghai Changzheng Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago